Genetic susceptibility to venous thrombosis.
Seligsohn
U
U
Institute of Thrombosis and Hemostasis and the National Hemophilia Center, Department of Hematology Chaim Sheba Medical Center, Tel Hashomer, Israel. zeligson@post.tau.ac.il
Lubetsky
A
A
D000925:Anticoagulants / Q000627:therapeutic use; D001777:Blood Coagulation / Q000502:physiology; D003276:Contraceptives, Oral / Q000009:adverse effects; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D012307:Risk Factors; D013917:Thrombin / Q000502:physiology; D019851:Thrombophilia / Q000150:complications / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology; D020246:Venous Thrombosis / Q000209:etiology / Q000235:genetics* / Q000628:therapy; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D003276:Contraceptives, Oral; D014859:Warfarin; D006493:Heparin; D013917:Thrombin